carcinoembryonic antigen cystic fibrosis protein blood cystic fibrosis homozygote heterozygote carrier carcinoembryonic antigen cea activity measured radioimmunoassay blood cystic fibrosis cf homozygote heterozygote carrier cf normal healthy control patient control carcinoma involving gastrointestinal organ sample also screened electrofocusing cystic fibrosis protein cfp metabolic marker previously shown associated cf gene significantly increased level cea activity found cfppositive group however one exception patient control marked increase cea activity cfp negative immunodiffusion perchloric acid extract cealike material heterozygote carrier blood indicated cealike material elevated homozygote heterozygote cf showed partial identity two separate cea preparation obtained colon carcinoma identical either b oh blood group substance glycoprotein material however react three different anticea antiserum finding abnormally increased glycoprotein cystic fibrosis taken together previous report demonstrating abnormality carbohydrate portion glycoprotein found various exocrine secretion cf suggests primary defect disease manifested partly defect glycoprotein metabolism defect may result abnormality one glycosyltransferases possibly caused primary defect polyamine metabolism